Kelly Mulder

Kelly Mulder is currently the Chief Scientific Officer at Bon Vivant. Prior to that, worked at Novozymes as an R&D Group Leader, leading a team of scientists and managing a product portfolio. Kelly also has experience as a research scientist at Integra Bioprocessos e Análises and as a visiting professor at Universidade de Brasília. With a PhD in Genetics of Microorganisms and a background in biology and biotechnology, Kelly has a strong foundation in scientific research and development.